alexa Abstract | A Review on Diabetes Mellitus Type II


Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access

Abstract

Diabetes mellitus is a worldwide health problem, which is a chronic metabolic disorder leads to defect in insulin secretion also causes restriction in metabolism of fats, carbohydrates and protein metabolism. The most effective anti-diabetic drugs currently available include insulin and sulphonylureas, biguanides, meglitinides, thiazolidinediones, alpha- glucosidase inhibitors, incretins, DPP-4 inhibitors, Amylin analogs. Worldwide 382 million people will have Diabetes mellitus. As the disease in severe conditions causes diabetic complications such as retinopathy, neuropathy, nephropathy, cardiovascular complications and ulceration. Diabetes mellitus is of several types among them type-1 and type-2 are major types. Type-2 DM is an incomplete understood chronic disease. It is noninsulin dependent Diabetes mellitus or adult-onset diabetes. it is characterized by hyperglycemia, means lack of insulin. The symptoms include excess thirst, frequent urination, and constant hunger. Type-2 Diabetes mellitus are about 90% cases of diabetes, other 10% belongs to type-1 and gestational diabetes. Currently available therapies for type II diabetes mellitus are as follows oral insulin secretagogues, sulfonylureas, repaglinide, nateglinide, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, insulin, pramlintide and exenatide. The aim of diabetes treatment is to secure a quality of life and lifespan comparable to those of healthy people and a prerequisite for this is the prevention of onset and progression of vascular complications. The need for earlier initiation of proactive intervention must be emphasized, as well as the importance of comprehensive (blood sugar, blood pressure, and lipids) intervention in attaining this goal

To read the full article Peer-reviewed Article PDF image

Author(s): T. Pradeep, C. Haranath

Keywords

Dipeptidyl peptidase-4, insulin, peptide analogues, type 2 diabetes, Diabetes Research and Clinical Practice,Diabetes Research and Clinical Practice

Recommended Journals

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords